ORIC PHARMACEUTICALS INC (ORIC) Top Institutional Shareholders
ORIC PHARMACEUTICALS INC (ORIC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.43B in ORIC holdings during the latest filing period.
Nextech Invest, Ltd. is currently the largest disclosed institutional shareholder of ORIC tracked by InsiderSet, reporting ownership valued at approximately $90.75M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $61.81M, representing an estimated loss of -31.89% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 46% of the total disclosed ORIC value among the investors covered in this analysis. Major shareholders include Nextech Invest, Ltd., Ecor1 Capital, Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in ORIC PHARMACEUTICALS INC (ORIC).
This page ranks the largest institutional ORIC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
180
Total Reported Value
$1.43B
Largest Holder
Nextech Invest, Ltd.
Largest Position
$90.75M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
180
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Nextech Invest, Ltd. | 6.39% | 7,162,637 | $90,750,611 | $61,813,557 | -$28,937,054 | -31.89% | |
| Ecor1 Capital, Llc | 3.64% | 6,728,116 | $85,245,230 | $58,063,641 | -$27,181,589 | -31.89% | |
| Blackrock, Inc. | 0.00% | 5,976,454 | $75,721,672 | $51,576,798 | -$24,144,874 | -31.89% | |
| Viking Global Investors | Ole Andreas Halvorsen | 0.21% | 5,824,533 | $73,796,833 | $50,265,720 | -$23,531,113 | -31.89% |
| Sr One Capital Management, Lp | 6.39% | 4,514,929 | $58,476,915 | $38,963,837 | -$19,513,078 | -33.37% | |
| Pfizer Inc | 24.14% | 4,780,401 | $57,651,636 | $41,254,861 | -$16,396,775 | -28.44% | |
| Alkeon Capital Management Llc | 0.26% | 4,504,096 | $57,066,896 | $38,870,348 | -$18,196,548 | -31.89% | |
| Venrock Adviser, Llc | 2.04% | 4,319,765 | $54,731,423 | $37,279,572 | -$17,451,851 | -31.89% | |
| Nea Management Company, Llc | 2.97% | 4,118,621 | $52,182,928 | $35,543,699 | -$16,639,229 | -31.89% | |
| State Street Corp | 0.00% | 3,702,196 | $46,906,823 | $31,949,951 | -$14,956,872 | -31.89% | |
| Vanguard Capital Management Llc | 0.00% | 3,687,007 | $46,714,379 | $31,818,870 | -$14,895,509 | -31.89% | |
| Column Group Llc | 44.55% | 3,540,777 | $44,861,645 | $30,556,906 | -$14,304,739 | -31.89% | |
| Siren, L.L.C. | 1.05% | 2,998,192 | $37,987,092 | $25,874,397 | -$12,112,695 | -31.89% | |
| Orbimed Advisors Llc | 0.74% | 2,693,929 | $34,132,080 | $23,248,607 | -$10,883,473 | -31.89% | |
| Aihc Capital Management Ltd | 26.04% | 2,459,551 | $31,162,511 | $21,225,925 | -$9,936,586 | -31.89% | |
| Fmr Llc | 0.00% | 2,434,080 | $30,839,793 | $21,006,110 | -$9,833,683 | -31.89% | |
| Citadel Advisors Llc | 0.02% | 2,422,741 | $30,696,128 | $20,908,255 | -$9,787,873 | -31.89% | |
| First Turn Management, Llc | 2.86% | 2,017,284 | $25,558,988 | $17,409,161 | -$8,149,827 | -31.89% | |
| Vivo Capital, Llc | 1.95% | 1,848,786 | $23,424,119 | $15,955,023 | -$7,469,096 | -31.89% | |
| Geode Capital Management, Llc | 0.00% | 1,838,801 | $23,302,207 | $15,868,853 | -$7,433,354 | -31.90% | |
| Mpm Bioimpact Llc | 1.77% | 1,803,945 | $22,855,983 | $15,568,045 | -$7,287,938 | -31.89% | |
| Paradigm Biocapital Advisors Lp | 0.44% | 1,701,217 | $21,554,419 | $14,681,503 | -$6,872,916 | -31.89% | |
| Morgan Stanley | 0.00% | 1,682,523 | $21,317,567 | $14,520,173 | -$6,797,394 | -31.89% | |
| Goldman Sachs Group Inc | 0.00% | 1,475,712 | $18,697,271 | $12,735,395 | -$5,961,876 | -31.89% | |
| Dimensional Fund Advisors Lp | 0.00% | 1,471,290 | $18,637,042 | $12,697,233 | -$5,939,809 | -31.87% | |
| Franklin Resources Inc | 0.00% | 1,452,835 | $18,407,419 | $12,537,966 | -$5,869,453 | -31.89% | |
| Integral Health Asset Management, Llc | 0.94% | 1,400,000 | $17,738,000 | $12,082,000 | -$5,656,000 | -31.89% | |
| Woodline Partners Lp | 0.06% | 1,247,515 | $15,806,015 | $10,766,054 | -$5,039,961 | -31.89% | |
| Royce & Associates Lp | 0.15% | 1,207,223 | $15,295,515 | $10,418,334 | -$4,877,181 | -31.89% | |
| Braidwell Lp | 0.48% | 1,128,040 | $14,292,267 | $9,734,985 | -$4,557,282 | -31.89% | |
| Silverarc Capital Management, Llc | 1.64% | 1,100,010 | $13,937,127 | $9,493,086 | -$4,444,041 | -31.89% | |
| Bank Of America Corp | 0.00% | 1,043,159 | $13,216,824 | $9,002,462 | -$4,214,362 | -31.89% | |
| Euclidean Capital Llc | 3.20% | 989,410 | $12,535,825 | $8,538,608 | -$3,997,217 | -31.89% | |
| Arrowmark Colorado Holdings Llc | 0.32% | 960,517 | $12,169,750 | $8,289,262 | -$3,880,488 | -31.89% | |
| Eventide Asset Management, Llc | 0.20% | 953,451 | $12,079,267 | $8,228,282 | -$3,850,985 | -31.88% | |
| Logos Global Management Lp | 0.62% | 950,000 | $12,036,500 | $8,198,500 | -$3,838,000 | -31.89% | |
| Qube Research & Technologies Ltd | 0.02% | 859,491 | $10,889,751 | $7,417,407 | -$3,472,344 | -31.89% | |
| Defilade Capital Management, L.P. | 1.50% | 842,928 | $10,679,898 | $7,274,469 | -$3,405,429 | -31.89% | |
| Northern Trust Corp | 0.00% | 710,861 | $9,006,608 | $6,134,730 | -$2,871,878 | -31.89% | |
| Sofinnova Investments, Inc. | 0.43% | 679,578 | $8,610,253 | $5,864,758 | -$2,745,495 | -31.89% | |
| Charles Schwab Investment Management Inc | 0.00% | 605,037 | $7,665,819 | $5,221,469 | -$2,444,350 | -31.89% | |
| Candriam S.C.A. | 0.04% | 574,085 | $7,273,657 | $4,954,354 | -$2,319,303 | -31.89% | |
| Vanguard Portfolio Management Llc | 0.00% | 570,691 | $7,230,655 | $4,925,063 | -$2,305,592 | -31.89% | |
| Polar Capital Holdings Plc | 0.03% | 539,377 | $6,833,907 | $4,654,824 | -$2,179,083 | -31.89% | |
| Sphera Funds Management Ltd. | 1.17% | 537,628 | $6,811,747 | $4,639,730 | -$2,172,017 | -31.89% | |
| Balyasny Asset Management L.P. | 0.01% | 523,790 | $6,636,419 | $4,520,308 | -$2,116,111 | -31.89% | |
| Nextbio Capital Management Lp | 3.08% | 523,619 | $6,634,253 | $4,518,832 | -$2,115,421 | -31.89% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.02% | 522,061 | $6,614,513 | $4,505,386 | -$2,109,127 | -31.89% | |
| Vanguard Fiduciary Trust Co | 0.00% | 507,294 | $6,427,415 | $4,377,947 | -$2,049,468 | -31.89% | |
| Redmile Group, Llc | 0.35% | 415,710 | $5,267,046 | $3,587,577 | -$1,679,469 | -31.89% |
Frequently asked questions about ORIC
Who owns the most ORIC stock?
The largest holders of ORIC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ORIC PHARMACEUTICALS INC (ORIC).
Is ORIC widely held by superinvestors?
Many widely followed stocks like ORIC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ORIC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.